Eric Chapuy

Clermont-ferrand, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

5-HT6 Receptor Inverse Agonists Modulate Diabetic Neuropathic Pain in Female Rats: Evidence for 5-HT6 Receptor Constitutive Activity.

5-HT6 Receptor Inverse Agonists Modulate Diabetic Neuropathic Pain in Female Rats: Evidence for 5-HT6 Receptor Constitutive Activity.

Journal: Journal of neurochemistry

Published: March 04, 2025

Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine.

Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine.

Journal: Toxics

Published: November 02, 2023

The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats.

The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats.

Journal: Biomolecules

Published: December 29, 2022

Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors.

Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 10, 2022

mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment.

mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment.

Journal: Progress in neurobiology

Published: December 17, 2019

TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.

TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.

Journal: British journal of pharmacology

Published: October 28, 2019

Effects of S 38093, an antagonist/inverse agonist of histamine H3 receptors, in models of neuropathic pain in rats.

Effects of S 38093, an antagonist/inverse agonist of histamine H3 receptors, in models of neuropathic pain in rats.

Journal: European journal of pain (London, England)

Published: July 30, 2017

Disruption of 5-HT2A-PDZ protein interaction differently affects the analgesic efficacy of SSRI, SNRI and TCA in the treatment of traumatic neuropathic pain in rats.

Disruption of 5-HT2A-PDZ protein interaction differently affects the analgesic efficacy of SSRI, SNRI and TCA in the treatment of traumatic neuropathic pain in rats.

Journal: Neuropharmacology

Published: February 21, 2017

Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity.

Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity.

Journal: Journal of medicinal chemistry

Published: January 05, 2017

Agomelatine: a new opportunity to reduce neuropathic pain-preclinical evidence.

Agomelatine: a new opportunity to reduce neuropathic pain-preclinical evidence.

Journal: Pain

Published: December 17, 2016

The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia.

The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia.

Journal: Cell reports

Published: August 01, 2014

Alleviating pain hypersensitivity through activation of type 4 metabotropic glutamate receptor.

Alleviating pain hypersensitivity through activation of type 4 metabotropic glutamate receptor.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: November 29, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026